BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21327940)

  • 1. Prevalence and clinical impact of autoimmune diseases and chronic infections in malignant lymphomas at diagnosis.
    Vanura K; Späth F; Gleiss A; Le T; Porpaczy E; Skrabs C; Hauswirth A; Fleiss K; Wessely F; Gaiger A; Müllauer L; Jäger U
    Ann Hematol; 2011 Aug; 90(8):947-54. PubMed ID: 21327940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma.
    Ramos-Casals M; Trejo O; García-Carrasco M; Cervera R; De La Red G; Gil V; López-Guillermo A; Ingelmo M; Font J
    J Rheumatol; 2004 Mar; 31(3):495-9. PubMed ID: 14994393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A; Berg R
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.
    Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A
    Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy.
    Luminari S; Cesaretti M; Rashid I; Mammi C; Montanini A; Barbolini E; Bellei M; Pennese E; Sirotti MA; Marcheselli L; Partesotti G; Bari A; Maiorana A; Bonacorsi G; Federico M
    Hematol Oncol; 2007 Dec; 25(4):189-97. PubMed ID: 17654762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant lymphomas in the elderly: a single institute experience highlights future directions.
    Váróczy L; Dankó A; Simon Z; Gergely L; Ress Z; Illés A
    Arch Gerontol Geriatr; 2007; 45(1):43-53. PubMed ID: 17079031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland.
    Zucca E; Roggero E; Maggi-Solcà N; Conconi A; Bertoni F; Reilly I; Castelli D; Pedrinis E; Piffaretti JC; Cavalli F
    Haematologica; 2000 Feb; 85(2):147-53. PubMed ID: 10681721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan.
    Chen WL; Tsai WC; Chao TY; Sheu LF; Chou JM; Kao WY; Chen YC; Ho CL
    Ann Hematol; 2010 Jun; 89(6):553-62. PubMed ID: 20012434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
    Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
    J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS-related lymphomas in Nigeria.
    Bolarinwa RA; Ndakotsu MA; Oyekunle AA; Salawu L; Akinola NO; Durosinmi MA
    Braz J Infect Dis; 2009 Oct; 13(5):359-61. PubMed ID: 20428636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis.
    Lim ST; Fei G; Quek R; Lim LC; Lee LH; Yap SP; Loong S; Tao M
    Eur J Haematol; 2007 Aug; 79(2):132-7. PubMed ID: 17635237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphomas.
    Chindamo MC; Spector N; Segadas JA; Pimenta G; Vanderborght B; Morais JC; Milito C; Moraes Coelho HS
    Oncol Rep; 2002; 9(3):657-9. PubMed ID: 11956646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary brain lymphomas after kidney transplantation: presentation and outcome.
    Snanoudj R; Durrbach A; Leblond V; Caillard S; Hurault De Ligny B; Noel C; Rondeau E; Moulin B; Mamzer-Bruneel MF; Lacroix C; Charpentier B
    Transplantation; 2003 Sep; 76(6):930-7. PubMed ID: 14508356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma glutathione S-Transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV).
    Katahira T; Takayama T; Miyanishi K; Hayashi T; Ikeda T; Takahashi Y; Takimoto R; Matsunaga T; Kato J; Niitsu Y
    Clin Cancer Res; 2004 Dec; 10(23):7934-40. PubMed ID: 15585627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
    Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
    Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
    Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.